Review:
Chemotherapy For Thyroid Malignancies
overall review score: 3
⭐⭐⭐
score is between 0 and 5
Chemotherapy for thyroid malignancies involves the use of cytotoxic drugs to treat various types of thyroid cancer, particularly in cases where surgery and radioactive iodine therapy are insufficient or not suitable. While chemotherapy is not the primary treatment for most differentiated thyroid cancers, it may be employed in advanced, refractory, or aggressive cases to control disease progression.
Key Features
- Use of cytotoxic drugs such as doxorubicin and cisplatin
- Typically reserved for advanced or RAI-refractory thyroid cancers
- May be combined with targeted therapies or radiation
- Potential systemic side effects including nausea, hair loss, and fatigue
- Treatment response varies based on cancer subtype and patient health
Pros
- Provides additional treatment option for refractory cases
- Can help control disease progression in advanced thyroid cancers
- May improve quality of life in certain patients when other treatments fail
Cons
- Limited effectiveness in differentiated thyroid cancers
- Significant side effects and toxicity concerns
- Often used as a palliative rather than curative approach
- Emerging targeted therapies are sometimes preferred